Navigation Links
Fish show autism-like gene expression in water with psychoactive pharmaceuticals
Date:6/8/2012

Psychoactive medications in water affect the gene expression profiles of fathead minnows in a way that mimics the gene expression patterns associated with autism spectrum disorder in genetically susceptible humans, according to research published June 6 in the open access journal PLoS ONE. These results suggest a potential environmental trigger for autism spectrum disorder in this vulnerable population, the authors write.

The researchers, led by Michael A. Thomas of Idaho State University, exposed the fish to three psychoactive pharmaceuticals fluoxetine, a selective serotonin reuptake inhibitor, or SSR1; venlafaxine, a serotonin-norepinephrine reuptake inhibitor, and carbamazepine, used to control seizures at concentrations comparable to the highest estimated environmental levels.

They found that the only gene expression patterns affected were those associated with idiopathic autism spectrum disorders, caused by genetic susceptibility interacting with unknown environmental triggers. These results suggest that exposure to environmental psychoactive pharmaceuticals may play a role in the development of autism spectrum disorder in genetically predisposed individuals.

Lead researcher Michael A. Thomas remarks, "While others have envisioned a causal role for psychotropic drugs in idiopathic autism, we were astonished to find evidence that this might occur at very low dosages, such as those found in aquatic systems."


'/>"/>

Contact: Lindsay Morton
lmorton@plos.org
415-935-2094
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
2. A new application allows online statistical analysis of gene-expression data
3. IU biologists offer clearer picture of how protein machine systems tweak gene expression
4. Microbial communities shifted dramatically after Deepwater Horizon spill
5. Scientists find that rain may not always be a welcome thing to waterbirds
6. Scientists discover huge phytoplankton bloom in ice-covered waters
7. The first pilot wastewater treatment plant with integrated wood production opened in Mongolia
8. Earths water cycle intensifying with atmospheric warming
9. Could cap and trade for water solve problems facing the United States largest rivers?
10. USF study: Common fungicide wreaks havoc on freshwater ecosystems
11. Begin early: Researchers say water with meals may encourage wiser choices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2019)... N.Y. (PRWEB) , ... November 21, 2019 , ... ... developed at Roswell Park Comprehensive Cancer Center have announced a major step forward ... Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park ...
(Date:11/19/2019)... ... 2019 , ... Project Lifeline – a community partnership and research ... substance use disorder (SUD) – will take center stage at the upcoming ... program’s effectiveness in preventing and treating opioid abuse in Blair County, Pennsylvania, will receive ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... The inaugural ... Times Square in New York City. The one-day event will be chaired by Dr ... of leaders in the space. , “We are witnessing significant innovation in cell ...
Breaking Biology News(10 mins):
(Date:11/22/2019)... ... , ... Lajollacooks4u is preparing for another busy holiday season. Not only ... its popular cooking classes and team-building events, but the company has also booked numerous ... been a favorite for companies of all sizes since 2008. Each event is ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical company developing T-cell ... their R&D operations related to the discovery and development of high-affinity and ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
Breaking Biology Technology: